THE SELFISH BRAIN THEORY
The Selfish Brain Clinical Research Group
www.selfish-brain.net 
Recent Publications:
Hendrik Lehnert, Professor of Internal Medicine, Endocrinology
Medical Clinic I, University of Luebeck, Germany

  1. Kopf, D., Cheng, LSC., Blandau, P., Hsueh, W., Raffel, LJ., Buchanan, TA., Xiang, AH., Davis, RC., Rotter, JI., Lehnert, H.: Association of insulin sensitivity and glucose tolerance with the c.825C>T variant of the G protein beta-3 subunit gene. J. Diab. Comp. In press.

  2. Raymond, NT., Zehnder, D., Smith, SCH, Stinson, JA., Lehnert, H., Higgins, RM.: Elevated relative mortality risk with mild to moderate chronic kidney disease decreases with age. Nephrol. Dial. Transplant. In press.

  3. Mundschenk, J., Schulz, S., Hollt, V., Neumann, H.P.H., Lehnert, H.: A catecholamine-secreting glomus tumour diagnosed by octreotide-scintigraphy and somatostatin receptor subtyping in a patient with malignant SDHB-associated paraganglioma. Exp.Clin. Endocrinol.Diabet. In press.

  4. Molostov, G., Bland, R., James, S., Fletcher, S., Bennett, J., Lehnert, H., Zehnder, D.: Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol. Epub ahead of print

  5. Tan, BK., Chen, J., Lehnert, H., Kennedy, R., Randeva, H.: Raised serum, adipocyte and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome:effects of gonadal and adrenal steroids. J Clin Endocrinol Metab. Epub ahead of print

  6. Markovic, D., Vatish, M., Gu, M., Slater, D., Newton R., Lehnert, H., Grammatopoulos, D.: The onset of labour alters corticotropin-releasing hormone type-1 receptor (CRH-R1) variant expression in human myometrium:putative role of IL-1 (beta). Endocrinology Epub ahead of print

  7. Schneider, H.J., Glaesmer, H., Klotsche, J., Böhler, S., Lehnert, H., Zeiher, A.M., März, W., Stalla, G.K., Wittchen, H.U : detect Study Group: Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J.Clin.Endocrinol.Metab. 92, 589-594, 2007

  8. Bramlage, P., Pittrow, D., Lehnert, H., Höfler, M., Kirch, W., Ritz, E., Wittchen, HU.: Frequency of Albuminuria in Primary Care: a cross sectional study. European Journal for Cardiovascular Prevention and Rehabiliation. 14, 107-113, 2007

  9. Boehler, S., Scharnagel, H., Freisinger, F., Stojakovic, T., Glaesmer, H., Klotsche, J., Pieper, L., Pittrow, D., Kirch, W., Schneider, H., Stalla, GK., Lehnert, H., Zeiher, A.M., Silber, S., Koch, U., Ruf, G., Wittchen, H.U., Marz, W.: DETECT-Study Group: Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis. 190, 307-407, 2007

  10. Scholz, T., Schulz, C., Klose, S., Lehnert, H.: Diagnostic management of benign and malignant pheochromocytoma. Exp Clin Endocrinol Diabetes. 115, 155-159, 2007

  11. Bramlage, P., Pittrow, D., Lehnert, H., Hofler, M., Kirch, W., Ritz, E., Wittchen, HU.: Frequency of albuminuria in primary care: a cross-sectional study. Eur J Cardiovasc Prev Rehabil. 14, 107-113, 2007

  12. Scholz, T., Eisenhofer, G., Pacak, K., Dralle, H., Lehnert, H.: Clinical Review: Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab. 92, 1217-1225, 2007

  13. Lehnert, H., Scholz, H., Schafer, M., Klose, S.: Endocrine Hypertension. Dtsch. Med. Wochenschr. 132, 634, 2007

  14. Heutling, D., Schulz, H., Randeva, H., Dodt, C., Lehnert, H.: Polycystic ovary syndrome: Prototype of a cardiometabolic syndrome. Internist. 48, 144-153, 2007

  15. Peters, A., Lehnert, H.: Metabolic Syndrome: Origin within the central nervous system? Internist. 48, 134-143, 2007

  16. Gimenez-Roqueplo, AP., Lehnert, H., Mannelli, M., Neumann, H., Opocher, G., Maher, ER., Plouin, PF: European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working Group: Phaeochromocytoma, new genes and screening strategies. Clin. Endocrinol. 65, 699-705, 2006

  17. Bramlage, P., Muhlen, I., Randeva, H., Spanswick, D., Lehnert, H.: Cardiovascular risk management by blocking the endocannabinoid system. Exp Clin Endocrinol Diabetes. 114, 75-81, 2006

  18. Reschke, K., Busse, S., Mohnike, K., Buchfelder, M., Ranke, M., Fahlbusch, R., Lehnert, H.: CranioNet – an interdisciplinary strategy for craniopharyngioma. Dtsch Med Wochenschr. 131, 821-824, 2006

  19. Gallwitz, B., Lehnert, H., Dittmann, H., Honegger, J., Teichmann, R., Tatagiba, M., Haring, HU.: Clinical pathways in endocrinology and diabetology. Internist (Berl). 47, 707-710, 2006

  20. Lehnert, H., Klose, S., Lobmann, R., Zehnder, D.: Microalbuminuria in diabetes: setting the points for treatment. MMW Fortschr Med. 148, 28-30, 2006

  21. Palmer, AJ., Roze, S., Rodby, RA., Valentine, WJ., Ritz, E., Lehnert, H.: Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy. Dtsch Med Wochenschr. 131, 1721-1726, 2006

  22. Digby, J.E., Chen, J., Tang, J.Y., Lehnert, H., Matthews, R.N., Randeva, H.S.: Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J.Endocrinol. 191, 129-136, 2006

  23. Pittrow, D., Stalla, G., Zeiher, A., Silber, S., März, W., Pieper, L., Klotsche, J., Glaesmer, H., Ruf, G., Schneider, H., Lehnert, H., Böhler, S., Koch, U., Wittchen, H.U.: Prävalenz, medikamentöse Behandlung und Stoffwechseleinstellung de Diabetes mellitus in der Hausarztpraxis. Med.Klinik. 101, 635-644, 2006

  24. Lobmann, R., Zemlin, C., Motzkau, M., Reschke, K., Lehnert, H.: Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a proteases absorbent dressing. J. Diab. Complic. 20, 329-325, 2006

  25. Lobmann, R., Pap, T., Ambrosch, A., Waldmann, K., Konig, W Lehnert, H.: Differential effects of PDGF-BB on matrix metalloproteases and cytokine release in fibroblasts of type-2 diabetic patients and normal controls in vitro. J.Diab.Complic. 20,105-112, 2006

  26. Dombrowski, F., Flaschka, S., Evert, M., Klotz, L., von Netzer, B., Schulz, C., Lehnert, H,. Evert, M.: Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats. Hepatology. 43, 857-867, 2006

  27. Fliedner, S., Schulz, C., Lehnert, H.: Brain uptake of intranasally applied radio-iodinated leptin in Wistar rats. Endocrinology. 147, 2088-2094, 2006

  28. Klose, S., Kopf, D., Lehnert, H.: Giant intrasellar carotid aneurysm – an unusual cause for panhypopituitarism. Exp.Clin.Endocrinol.Diabet. 113, 551-553, 2005

  29. Gilles, M., Kopf, D., Lehnert, H., Deuschle, M.: Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity – implication for atypical antipsychotics. Psychosom.Med. 67, 748-751, 2005

  30. Wittchen, H.U., Glaesmer, H., Marz, W., Stalla, G., Lehnert, H., Zeiher, A.M., Silber, S., Koch, U., Bohler, S., Pittrow, D., Ruf, G.: DETECT – Study Group: Cardiovascular risk factors in primary care: methods and baseline prevalence rates – The DETECT Program. Curr.Med.Res.Opin. 21, 619-630, 2005

  31. Machens, A., Brauckhoff, M., Holzhausen, HJ., Thanh, PN., Lehnert, H., Dralle, H: Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type-2. J.Clin.Endocrinol.Metabol. 90, 3999-4003, 2005

  32. Rotte, M., Barecke, C., Pottag, G., Klose, S., Kanneberg, E., Heinze, HJ., Lehnert, H.: Insulin affects the neuronal response in the medial temporal lobe in humans. Neuroendocrinology. 81, 49-55, 2005

  33. Paulus, K., Schulz, C., Lehnert, H.: Central nervous effects of leptin and insulin on hippocampal leptin and insulin receptor expression following a learning task in wistar rats. Neuropsychobiology. 51, 100-106, 2005

  34. Lehnert, H., Wittchen, H.U., Pittrow, D., Bramlage, P., Kirch, W., Bohler, S., Hofler, M., Ritz, E.: Prevalence and pharmacotherapy of diabetes mellitus in primary care. Dtsch.Med.Wochenschr. 130, 323-328, 2005

  35. Lobmann, R., Schultz, G., Lehnert, H.: Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diab.Care. 28, 461-471, 2005

  36. Lobmann, R., Ittenson, A., Schieweck, K., Motzkau, M., Winkler, S., Schraven, B., Lehnert, H.: Expression of cell surface antigenes in diabetic patients and healthy controls after injury. Diab.Nutr.Metab. 17, 244-246, 2004

  37. Bramlage, P., Pittrow, D., Wittchen, H.U., Kirch, W., Böhler, S., Lehnert, H., Höfler, M., Unger, T., Sharma, A.M.: Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am. J.Hypertension. 17, 904-910, 2004

  38. Bramlage, P., Wittchen, H.U., Pittrow, D., Kirch, W., Krause, P., Lehnert, H., Unger, T., Höfler, M., Küpper, B., Dahms, S., Böhler, S., Sharma, A.M.: Recognition and management of overweight and obesity in primary care patients in Germany. Int.J.Obes. 28, 1299-1308, 2004

  39. Kopf, D., Westphal, S., Luley, C., Ritter, S., Gilles, M., Weber-Hamann, B., Lederbogen, F., Lehnert, H., Henn, F., Heuser, I., Deuschle, M.: Lipid metabolism and insulin resistance in depressed patients: significance of BMI, HPA system activity and antidepressant treatment. J.Clin.Psychopharmacol. 24, 527-531, 2004

  40. Eisenhofer, G., Bornstein, S.R., Brouwers, F.M., Cheung, N.K., Dahia, P.L., De Krijger, R.R., Giordano, T.J., Greene, L.A., Goldstein,D.S. Lehnert, H., Manger, W.M., Maris, J.M., Neumann, N.P., Pacak, K., Shulkin, B.L., Smith, D.I., Tischler, A.S., Young, Jr. W.F.: Malignant pheochromocytoma: current status and initiatives for future progress. Endocr.Relat.Caner. 11, 423-436, 2004

  41. Heutling, D., Dieterich, K.C., Buchfelder, M., Lehnert, H.: Mutation analysis of leukaemia inhibitory factor receptor (LIF-R) in ACTH-secreting pituitary adenomas. Exp.Clin.Endocrinol.Diab. 112, 458-461, 2004

  42. Lobmann, R., Ambrosch, A., Seewald, M., Dietlein, M., Zink, K., Kullmann, K.H., Lehnert, H.: Antibiotic therapy for diabetic foot infections:comparison of cephalosporines with chinolones. Diab.Nutr.Metabol. 17, 156-162, 2004

  43. Steckelings, U.M., Stoppelhaar, M., Sharma, A.M., Wittchen, H.U., Krause, P., Küpper, B., Kirch, W., Pittrow, D., Ritz, E., Goke, B., Lehnert, H., Tschope, D., Höfler, M., Pfister, H., Unger, T.: HYDRA: Factors associated with poor hypertension control in German primary care patients. Blood.Pressure. 13, 80-88, 2004

  44. Böhler, S., Glaesmer, H., Pittrow, D., Lehnert, H., Stalla, G., Zeiher, A., März, W., Silber, S., Wehling, M., Ruf, G., Reinecke, A., Wittchen, H.M.: Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues. Exp.Clin.Endocrinol.Diab. 112,157-170, 2004

  45. Pittrow, D., Kirch, W., Bramlage, P., Lehnert, H., Höfler, M., Unger, T., Wittchen, H.U.: Antihypertensive drug utilization in primary care. Eur.J.Clin.Pharmacol. 60, 135-142, 2004

  46. Schulz, C., Paulus, K., Lehnert, H.: Central nervous and metabolic effects of intranasally applied leptin. Endocrinology. 145, 2696-2701, 2004

  47. Sharma, A.M., Wittchen, H.U., Kirch, W., Pittrow, D., Ritz, E., Goke, B., Lehnert, H., Tschope D., Krause, P., Hofler, M., Pfister, H., Bramlage, P., Unger, T.: Physician and self-reported prevalence of hypertension in primary care in Germany. J.Hypertension. 22, 479-486, 2004

  48. Sharma, A.M., Wittchen, H.U., Kirch, W., Pittrow, D., Ritz, E., Goke, B., Lehnert, H., Tschope D., Krause, P., Hofler, M., Pfister, H., Bramlage, P., Unger, T.:High prevalence and poor control of hypertension in primary care: Cross-sectional study. J.Hypertension. 22, 1-9, 2004

  49. Lehnert, H., Bramlage, P., Pittrow, D., Kirch, W.: Regression of microalbuminuria in type-2 diabetes after switch to irbesartan treatment. Clin.Drug.Invest. 24, 217-225, 2004

  50. Düsing, R., Lehnert, H.: Diabetogenic effect of antihypertensive treatment: primum nil nocere. Nephrol.Dial.Transplant. 19, 531-534, 2004

  51. Wittchen, H.-U., Krause, P., Höfler, M., Pfister, H., Küpper, B., Pittrow, D., Bramlage, P., Unger, T., Sharma, A.M., Ritz, E., Göke, B., Lehnert, H., Tschöpe, D., Kirch, W.: Ziel, Design und Methodik der "Hypertension and Diabetes Risk Screening and Awareness" -(HYDRA)-Studie. Fortschr. Med., 121, 2-11, 2003

  52. Mantke, R., Pross, M., Klose, S., Lehnert, H., Lippert, H.: Einsatz des Ultraschallskalpells in der konventionellen Schilddrüsenchirugie. Chirurg. 74, 739-742, 2003

  53. Mundschenk J., Unger, N., Schulz, S., Höllt, V., Lehnert, H.: Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scinitgraphy. J.Clin.Endocrinol.Metabol. 88, 5150-5157, 2003

  54. Boltze, C., Mundschenk, J., Unger, N., Schneider-Stock, R., Mawrin, C., Hoang-Vu, C., Roessner, A., Lehnert, H.: Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. J.Clin.Endocrinol.Metabol. 88, 4280-4286, 2003

  55. Lobmann, R., Pittasch, D., Mühlen, I., Lehnert, H.: Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in non-healing diabetic foot lesions –a pilot study. J.Diab.Complic. 17, 199-204, 2003

  56. El-Haschimi, K., Lehnert, H.: Leptin resistance – or why leptin fails to work in obesity. Exp.Clin.Endocrinol.Diab. 111, 2-7, 2003

  57. Gudat, U., Kühn, C., Kazda, C., Lehnert, H.: Insulin lispro bei übergewichtigen Patienten mit Diabetes mellitus Typ 2. Diabetes und Stoffwechsel. 12, 3, 2003

  58. Pittrow, D., Wittchen, H.U., Kirch, W., Unger, T., Krause, P., Sharma, A., Ritz, E., Göke, B., Lehnert, H., Tschöpe, D.: Hypertension and Diabetes Risk Screening and Awareness Study (HYDRA): Prevalence of hypertension and diabetes in primary care in Germany. Eur.J. Clin.Pharmacol. 58, 77, 2002

  59. Pittasch, D., Lobmann, R., Behrens-Baumann, W., Lehnert, H.: Pupillary autonomic denervation and diabetes mellitus. Br.J.Opthalmol. 86, 13-19, 2002

  60. Pittasch, D., Lobmann, R., Behrens-Baumann, W., Lehnert, H.: Pupil signs of sympathetic autonomic neuropathy in aptients with type 1 diabetes mellitus. Diab.Care. 25, 1545-1550, 2002

  61. Pross, M., Manger, T., Heres, F., Klose, S., Lehnert, H., Riewelski, K., Wolff., S., Mantke, R., Marusch, F., Lippert, H.: Laparoskopische Adrenalektomie. Zentralbl.Chir. 127, 610-613, 2002

  62. Lobmann, R., Kasten, G., Kasten, U., Lehnert, H.: Association of increased plantar pressures with peripheral sensorimotor and autonomic neuropathy in type-2 diabetic patients. Diab.Nutr.Meatb. 15, 165-168, 2002

  63. Lobmann, R., Ambrosch, A., Schultz, G., Waldmann, K., Schieweck, S., Lehnert, H.: Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 45, 1011-1016, 2002

  64. Reschke, K., Klose, S., Mohnike, K., Buhtz, P., Roessner, A., Lehnert, H.: Manifestation eines Cushing-Syndrom und osteoportische Frakturen in der Schwangerschaft einer Patienten mit Carney-Komplex. Med.Klinik. 97, 91-95, 2002

  65. Schulz, C., Wieczorek, I., Reschke, K., Lehnert, H.: Effects of intracerebroventricularly and intraperitoneally applied growth hormone on body weight and food intake in fa/fa Zucker rats. Neuropsychobiol. 45, 36-40, 2002

  66. Kopf, D., Schmitz, H., Beyer, J., Frank, M., Bockisch, A., Dubois, F., Lehnert, H.: A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy. Diab.Nutr.Metabol. 14, 245-252, 2001

  67. Wieczorek, I., Schulz, C., Jarry, H., Lehnert, H.: The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone. Int.J.Obes. 25, 1566-1569, 2001

  68. Mundschenk J., Rittig, S., Siggard, C., Hensen, J., Lehnert, H.: A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus. Exp.Clin.Endocrinol.Diabetes. 109, 406-409, 2001

  69. Parving, H.H., Lehnert, H. Bröchner-Mortensen, J., Gomis, R., Frangin, G., Andersen, S., Arner, P.: The effect of Irbesartan on development of diabetic nephropathy in patient with type 2 diabetes. New.Engl.J.Med. 345, 870-878, 2001

  70. Asbach, S., Schulz, C., Lehnert, H.: Effects of corticotropin-releasing hormone on noradrenergic locus coeruleus neurons in vivo: a microdialysis study using a novel bilateral injection design. Eur.J.Endocrinol. 145, 359-363, 2001

  71. Kopf, D., Mühlen, I., Kröning, G., Sendzik, I., Huschke, B., Lehnert, H.: Insulin sensitivity and endocrine regulation of sodium excretion and blood pressure in offspring of hypertensive parents. Metabolism. 50, 929-935, 2001

  72. Lobmann, R., Kayser, R., Kasten, G., Kasten, U., Kluge, K., Neumann, W., Lehnert, H.: The effects of preventative footwear on foot pressure as determined by pedobarography in diabetic patients: a prospective study. Diabet.Med. 18, 314-319, 2001

  73. Kopf, D., Lehnert, H.: Prädiktive Untersuchungen des metabolischen Syndroms. Dtsch.Med.Wschr. 126, 235-240, 2001

  74. Ambrosch, A., Dierkes, J., Lobmann, R., Kühne, W., Luley, C., König, W., Lehnert, H.: Relation between homocysteinemia and diabetic neuropathy in patients with type-2 diabetes mellitus. Diabet.Med. 18, 185-192, 2001

  75. Kopf, D., Goretzki, P., Lehnert, H.: Clinical management of malignant adrenal tumours. J.Cancer.Res.Clin.Oncol. 127, 143-155, 2001

  76. Hanisch, A., Dieterich, K.D., Buchfelder, M., Fahlbusch, R., Lehnert, H.: Expression of members of the Interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenoma. J.Clin.Endocrinol.Metabol. 85, 4411-4444, 2000

  77. Reschke, K., Klose, S., Ridwelski, K., Lehnert, H.: Obesity: sometimes more than adipose tissue. Lancet. 356, 734, 2000

  78. Lobmann, R., Smid, H.G., Pottag, G., Wagner, K., Heinze, H.J., Lehnert, H.: Impairment and recovery of elementary cognitive function induced by hypoglycaemia in type-1 diabetic patients and healthy controls. J.Clin.Endcrinol.Metabol. 85, 2758-2766, 2000

  79. Pittasch, D., Klose, S., Schmitt, J., Roessner, A., Ridwelski, K., Lippert, H., Lehnert, H.: Retroperitoneal schwannoma presenting as an adrenal tumour. Exp.Clin.Endocrinol.Diab. 108, 318-321, 2000

  80. Dieterich, K.D., Lehnert, H.: Decreased expression of corticotropin-releasing factor binding protein mRNA in ACTH-producing pituitary adenomas. Exp.Clin.Endocrinol.Diab. 108, 59-62, 2000

  81. Engelbach, M., Kunt, T., Kann, P., Manfras, B., Hankeln, T., Forst, T., Pfützner, A., Heerdt, S., Walgenbach, S., Lehnert, H., Beyer, J.: Prädiktive genetische Untersuchungen. Individualisierung von Diagnostik und Therapie bei Familien mit multipler endokriner Neoplasie Typ 2. Dtsch.Med.Wschr. 125, 37-44, 2000

  82. Deodare, S.S., Bilbao, I.M., Kovacs, K., Horvath, E., Nomikas, P., Buchfelder, M., Reschke, K., Lehnert, H.: Xanthomatous Hypophysitis. A novel entity of obscure etiology. Endocrine.Pathology. 10, 237-241, 1999

  83. Mundschenk, J., Klose, S., Lorenz, K., Dralle, H., Lehnert, H.: Diagnostic strategies and surgical procedures in persistent and recurrent hyperparathyroidism. Exp.Clin.Endocrinol.Diabetes. 107, 331-336, 1999

  84. Ambrosch, A., Lobmann, R., Dierkes, J., König, W., Luley, C., Lehnert, H.: Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a german non-insulin dependent population. Clin.Chem.Lab.Med. 37, 719-721, 1999

  85. Knoke, I., Jakubiczka, S., Lehnert, H., Wieacker, P.: A new point mutation of the androgen receptor gene in a patient with androgen resistance and severe oligozoospermia. Andrologia. 31, 199-201, 1999

  86. Dieterich, K.D., Lehnert, H.: Expression of leptin receptor mRNA and the long form splice variant in human anterior pituitary and pituitary adenoma. Exp.Clin.Endocrinol.Diabetes. 106, 522-525, 1998

  87. Ambrosch, A., Mühlen, I., Kopf, D., Augustin, W., Dierkes, J., Luley, C., Lehnert, H.: LDL size distribution in relation to insulin sensitivity, triglycerides and cholesterol ester transfer protein activity in young and healthy subjects. Diab.Care. 21, 2077-2084, 1998

  88. Reschke, K., Klose, S., Kopf, D., Lehnert, H.: Role of the ultrasound in the diagnostic of thyroid autonomy. Exp.Clin.Endocrinol.Diabetes. 106, 542-546, 1998

  89. Mundschenk, J., Lehnert, H.: Malignant pheochromocytoma. Exp.Clin.Endocrinol.Diabetes. 106, 373-376, 1998

  90. Dieterich, K.D., Gundelfinger, E.D., Lüdecke, D.K., Lehnert, H.: Mutation and expression analysis of the corticotropin-releasing factor 1 receptor in ACTH-secreting pituitary adenomas. J.Clin.Endocrinol.Metabol. 83, 3327-3331, 1998

  91. Hollenbach, E., Schulz, C., Lehnert, H.: Rapid and sensitive determination of catecholamines and the metabolite 3-Methoxy-4-Hydroxy-Phenylglycol (MHPG) using HPLC following a novel extraction procedure. Life.Sci. 63, 737-750, 1998

  92. Lehnert, H., Schulz, C., Dieterich, K.: Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus. Neurochem.Res. 23, 1039-1052, 1998

  93. Lehnert, H.: Regulation of catecholamine synthesizing enzyme gene expression in human pheochromocytoma. Eur.J.Endocrinol. 138, 363-367, 1998